AM
AnGes, Inc.
AMGXF · OTC
$0.36 +0.00% (+$0.00)
Market Cap ¥22.6B
P/E Ratio -
Div. Yield -
ROE 162.36%
Piotroski F-Score Weak
2/9Valuation
0 /100
Expensive P/B 110.85x
P/S 23.47x
P/FFO N/A
Growth
78 /100
Growing Book val. growth 53.40%
Rev. growth 135.41%
FCF growth N/A
Profitability
18 /100
Weak Op. margin 621.56%
Gross margin 41.35%
FCF margin 0.00%
Quality
3 /100
Poor ROA 106.71%
ROIC 581.32%
Asset turnover 0.27x
Debt
8 /100
High Int. coverage -388.66x
Debt/Equity 3.52x
Current ratio 0.95x
Stability
26 /100
Unstable EPS volatility 171.29%
Beta 0.61x
Profitable years 0
Bulios Scoring popisuje kvalitu a minulost firmy, ne budoucí výnos. Vysoké skóre není nákupní signál. Zjistit více
Zeptejte se StockBota na AMGXF
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Ei Yamada
Employees
56
Headquarters
Ibaraki
Nadcházející události
06 LIS
Earnings
Upcoming earnings report